[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Ferring International Center SA - Strategic SWOT Analysis Review

March 2021 | 29 pages | ID: F5D0071E613EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Ferring International Center SA (Ferring), a subsidiary of Ferring Holding SA researches, develops and markets pharmaceutical products. The company offers products in the fields of reproductive health, endocrinology, gastroenterology, urology and orthopedics. Its key products include Rekovelle (follitropin delta), for controlled ovarian stimulation; Menopur (HP-hMG) for female and male infertility; and Firmagon (degarelix) for prostate cancer. Its pipeline products encompass FE 999310 for infertility; FE 202767 for Lactation; FE 201836 for Nocturia among others. It has production facilities in Europe, Asia and a manufacturing site in the US. Ferring is headquartered in Saint-Prex, Switzerland.

Ferring International Center SA Key Recent Developments

Jul 22,2020: Ferring appoints Mirjam Mol-Arts to executive committee

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Ferring International Center SA - Key Facts
Ferring International Center SA - Key Employees
Ferring International Center SA - Key Employee Biographies
Ferring International Center SA - Major Products and Services
Ferring International Center SA - History
Ferring International Center SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Ferring International Center SA - Business Description
Ferring International Center SA - SWOT Analysis
SWOT Analysis - Overview
Ferring International Center SA - Strengths
Ferring International Center SA - Weaknesses
Ferring International Center SA - Opportunities
Ferring International Center SA - Threats
Ferring International Center SA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ferring International Center SA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jul 22, 2020: Ferring appoints Mirjam Mol-Arts to executive committee

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ferring International Center SA, Key Facts
Ferring International Center SA, Key Employees
Ferring International Center SA, Key Employee Biographies
Ferring International Center SA, Major Products and Services
Ferring International Center SA, History
Ferring International Center SA, Other Locations
Ferring International Center SA, Subsidiaries
Ferring International Center SA, Key Competitors
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ferring International Center SA, Recent Deals Summary

LIST OF FIGURES

Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications